id | C00001576 |
---|---|
Name | Lycorine / (-)-Lycorine |
CAS RN | 476-28-8 |
Standard InChI | InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 1156 |
By standard InChI | CHEMBL400092 |
---|---|
By standard InChI Main Layer | CHEMBL224745 CHEMBL400092 CHEMBL583716 CHEMBL577635 CHEMBL1592744 CHEMBL1593638 |
By LinkDB | C08532 |
---|
By CAS RN | C015330 |
---|
class name | count |
---|---|
Liliopsida | 48 |
family name | count |
---|---|
Amaryllidaceae | 47 |
Hyacinthaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1592744 |
CHEMBL1614110
(1)
CHEMBL1741321
(1)
|
1 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL400092 CHEMBL1592744 CHEMBL1593638 |
CHEMBL1613842
(3)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1592744 |
CHEMBL2114784
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL400092 |
CHEMBL1794499
(1)
|
2 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL1592744 |
CHEMBL1614544
(1)
|
11 / 10 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1592744 |
CHEMBL1741325
(1)
|
0 / 1 |
P11387 | DNA topoisomerase 1 | Isomerase | CHEMBL400092 |
CHEMBL1925808
(1)
|
0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL400092 |
CHEMBL1925807
(1)
|
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL1593638 |
CHEMBL1794311
(1)
|
2 / 3 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1592744 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL1592744 |
CHEMBL1613808
(1)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1592744 |
CHEMBL1741322
(1)
|
0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL400092 |
CHEMBL925438
(1)
CHEMBL1227598
(1)
|
1 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1593638 |
CHEMBL1614240
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1592744 |
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL400092 CHEMBL1592744 |
CHEMBL1029448
(1)
CHEMBL1741324
(1)
|
0 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1593638 |
CHEMBL1794536
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL1593638 |
CHEMBL1613914
(1)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL400092 |
CHEMBL1738442
(1)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL1593638 |
CHEMBL1614364
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C015330 | 896 |
CCND3
|
cyclin D3 | lycorine results in decreased expression of CCND3 mRNA |
decreases expression
|
mRNA |
23376478
|
C015330 | 1003 |
CDH5
7B4 CD144 |
cadherin 5, type 2 (vascular endothelium) | lycorine results in decreased expression of CDH5 mRNA |
decreases expression
|
mRNA |
23376478
|
C015330 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | lycorine results in increased expression of CDKN1A mRNA |
increases expression
|
mRNA |
23376478
|
C015330 | 10507 |
SEMA4D
C9orf164 CD100 M-sema-G SEMAJ coll-4 |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | lycorine results in decreased expression of SEMA4D mRNA |
decreases expression
|
mRNA |
23376478
|
C015330 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | lycorine results in decreased expression of VEGFA mRNA |
decreases expression
|
mRNA |
23376478
|
OMIM | preferred title | UniProt |
---|---|---|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D009325 | C015330 | Nausea |
marker/mechanism
|
21626407
|
|
D009389 | C015330 | Neovascularization, Pathologic |
therapeutic
|
23376478
|
|
D010051 | C015330 | Ovarian Neoplasms |
therapeutic
|
23376478
|
|
D012772 | C015330 | Shock, Septic |
therapeutic
|
22155741
|
|
D014839 | C015330 | Vomiting |
marker/mechanism
|
21626407
|